<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_vwZhv7h">• Special Issue 3: Personalized (N-of-1) Trials The Family of Single-Case Experimental Designs</title>
				<funder ref="#_MYwfnbp">
					<orgName type="full">National Institute on Aging of the National Institutes of Health</orgName>
				</funder>
				<funder ref="#_kUh9pSn #_8jUcn7A">
					<orgName type="full">National Institute of Diabetes and Digestive and Kidney Diseases</orgName>
					<orgName type="abbreviated">NIDDK</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000062</idno>
				</funder>
				<funder ref="#_rGQm8wD #_GA7ufnh">
					<orgName type="full">National Library of Medicine of the National Institutes of Health</orgName>
				</funder>
				<funder>
					<orgName type="full">Eunice Kennedy Shriver National Institute of Child Health and Human Development</orgName>
					<orgName type="abbreviated">NICHD</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100009633</idno>
				</funder>
				<funder ref="#_5vHyqxb">
					<orgName type="full">National Heart, Lung, and Blood Institute</orgName>
					<orgName type="abbreviated">NHLBI</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000050</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">License: Creative Commons Attribution 4.0 International License (CC-BY 4.0)</p>
				</availability>
				<date type="published" when="2022-09-08">Sep 08, 2022</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Leonard</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Jacobs School of Medicine and Biomedical Sciences , Division of Behavioral Medicine , Department of Pediatrics , University at Bu alo , Bu alo , New York , United States of America ,</note>
								<orgName type="department" key="dep1">Jacobs School of Medicine and Biomedical Sciences</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="department" key="dep3">Department of Pediatrics</orgName>
								<orgName type="institution">University at Bu alo</orgName>
								<address>
									<addrLine>Bu alo</addrLine>
									<region>New York</region>
									<country key="US">United States of America</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jesse</forename><surname>Dallery</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Psychology , University of Florida , Gainesville , Florida , United States of America</note>
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<region>Florida</region>
									<country key="US">United States of America</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">The MIT</note>
								<orgName type="institution">The MIT</orgName>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_5jGyErY">• Special Issue 3: Personalized (N-of-1) Trials The Family of Single-Case Experimental Designs</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2022-09-08">Sep 08, 2022</date>
						</imprint>
					</monogr>
					<idno type="MD5">27479085E9DB18EEE3CDD7308E6D2E7F</idno>
					<idno type="DOI">10.1162/99608f92</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_cdPGS8X">single-case experimental designs</term>
					<term xml:id="_uZJxtzb">reversal designs</term>
					<term xml:id="_mX8PsAp">multiple baseline designs</term>
					<term xml:id="_UBqtykc">personalized medicine</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_v7EKKvF"><p xml:id="_vd2qm2Q"><s xml:id="_MCh3vRE">Single-case experimental designs (SCEDs) represent a family of research designs that use experimental methods to study the effects of treatments on outcomes.</s><s xml:id="_pVjkKpY">The fundamental unit of analysis is the single casewhich can be an individual, clinic, or community-ideally with replications of effects within and/or between cases.</s><s xml:id="_mJcb32f">These designs are flexible and cost-effective and can be used for treatment development, translational research, personalized interventions, and the study of rare diseases and disorders.</s><s xml:id="_pfuhcQh">This article provides a broad overview of the family of single-case experimental designs with corresponding examples, including reversal designs, multiple baseline designs, combined multiple baseline/reversal designs, and integration of single-case designs to identify optimal treatments for individuals into larger randomized controlled trials (RCTs).</s></p><p xml:id="_Q856UpM"><s xml:id="_ezfruzS">Personalized N-of-1 trials can be considered a subcategory of SCEDs that overlaps with reversal designs.</s></p><p xml:id="_X8AUBRs"><s xml:id="_CBZWuyC">Relevant issues for each type of design-including comparisons of treatments, design issues such as randomization and blinding, standards for designs, and statistical approaches to complement visual inspection of single-case experimental designs-are also discussed.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="20" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="21" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1." xml:id="_RZ4JR56">Introduction</head><p xml:id="_4y7VcF4"><s xml:id="_JHwtcEw">Single-case experimental designs (SCEDs) represent a family of experimental designs to examine the relationship between one or more treatments or levels of treatment and changes in biological or behavioral outcomes.</s><s xml:id="_b6p3AG9">These designs originated in early experimental psychology research <ref type="bibr" target="#b4">(Boring, 1929;</ref><ref type="bibr" target="#b15">Ebbinghaus, 1913;</ref><ref type="bibr" target="#b47">Pavlov, 1927)</ref>, and were later expanded and formalized in the fields of basic and applied behavior analysis <ref type="bibr" target="#b44">(Morgan &amp; Morgan, 2001;</ref><ref type="bibr" target="#b62">Sidman, 1960)</ref>.</s><s xml:id="_G9UEVm4">SCEDs have been extended to a number of fields, including medicine <ref type="bibr" target="#b35">(Lillie et al., 2011;</ref><ref type="bibr" target="#b55">Schork, 2015)</ref>, public health <ref type="bibr" target="#b2">(Biglan et al., 2000;</ref><ref type="bibr" target="#b14">Duan et al., 2013)</ref>, education <ref type="bibr" target="#b23">(Horner et al., 2005)</ref>, counseling psychology <ref type="bibr" target="#b37">(Lundervold &amp; Belwood, 2000)</ref>, clinical psychology <ref type="bibr" target="#b67">(Vlaeyen et al., 2020)</ref>, health behavior <ref type="bibr" target="#b39">(McDonald et al., 2017)</ref>, and neuroscience <ref type="bibr" target="#b64">(Soto, 2020)</ref>.</s></p><p xml:id="_288XvVs"><s xml:id="_WMdMK3f">SCEDs provide a framework to determine whether changes in a target behavior(s) or symptom are in fact a function of the intervention.</s><s xml:id="_nmkewqj">The fundamentals of an SCED involve repeated measurement, replication of conditions (e.g., baseline and intervention conditions), and the analysis of effects with respect to each individual serving as his or her own control.</s><s xml:id="_ygZ5G2s">This process can be useful for identifying the optimal treatment for an individual <ref type="bibr" target="#b12">(Dallery &amp; Raiff, 2014;</ref><ref type="bibr" target="#b13">Davidson et al., 2021)</ref>, treating rare diseases <ref type="bibr" target="#b0">(Abrahamyan et al., 2016)</ref>, and implementing early phase translational research <ref type="bibr" target="#b10">(Czajkowski et al., 2015)</ref>.</s><s xml:id="_ubdBUkA">SCEDs can be referred to as 'personalized (N-of-1) trials' when used this way, but they also have broad applicability to a range of scientific questions.</s><s xml:id="_hvRkCc8">Results from SCEDs can be aggregated using meta-analytic techniques to establish Harvard Data Science Review • Special Issue 3: Personalized (N-of-1)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7kf2dGq">Trials</head><p xml:id="_xbuUDZA"><s xml:id="_eVtNV2d">The Family of Single-Case Experimental Designs 3 generalizable methods and treatment guidelines <ref type="bibr" target="#b60">(Shadish, 2014;</ref><ref type="bibr" target="#b66">Vannest et al., 2018)</ref>.</s><s xml:id="_vajJ2WB">Figure <ref type="figure" target="#fig_0">1</ref> presents the main family of SCEDs, and shows how personalized (N-of-1) trials fit into these designs <ref type="bibr" target="#b69">(Vohra et al., 2016)</ref>.</s></p><p xml:id="_67VxNBk"><s xml:id="_dV8qynS">The figure also distinguishes between experimental and nonexperimental single-case designs.</s><s xml:id="_GazqXZR">In the current article, we provide an overview of SCEDs and thus a context for the articles in this special issue focused on personalized (N-of-1) trials.</s><s xml:id="_hCBWcW2">Our focus is to provide the fundamentals of these designs, and more detailed treatments of data analysis <ref type="bibr" target="#b42">(Moeyaert &amp; Fingerhut, 2022;</ref><ref type="bibr" target="#b56">Schork, 2022)</ref> conduct and reporting standards <ref type="bibr" target="#b31">(Kravitz &amp; Duan, 2022;</ref><ref type="bibr" target="#b48">Porcino &amp; Vohra, 2022)</ref>, and other methodological considerations are provided in this special issue.</s><s xml:id="_pQrCRXu">Our hope is that this article will inspire a diverse array of students, engineers, scientists, and practitioners to further explore the utility, rigor, and flexibility of these designs.</s></p><p xml:id="_jsUr5UQ"><s xml:id="_dCNyUg6">The most common approach to evaluating the effectiveness of interventions on outcomes is using randomized controlled trials (RCTs).</s><s xml:id="_cskThWd">RCTs provide an idea of the average effect of an intervention on outcomes.</s><s xml:id="_jPsagSN">People do not all change at the same rate or in the same way, however; variability in both how people change and the effect of the intervention is inevitable <ref type="bibr" target="#b17">(Fisher et al., 2018;</ref><ref type="bibr" target="#b46">Normand, 2016;</ref><ref type="bibr" target="#b53">Roustit et al., 2018)</ref>.</s><s xml:id="_WFV7P2y">These sources of variability are conflated in a typical RCT, leading to heterogeneity of treatment effects (HTE).</s><s xml:id="_kbeum2P">Research on HTE has shown variability in outcomes in RCTs, and in some studies very few people actually exhibit the benefits of that treatment <ref type="bibr" target="#b73">(Williams, 2010)</ref>.</s><s xml:id="_cyesMVt">One approach in RCTs is to assess moderators of treatment response to identify individual differences that may predict response to a treatment.</s><s xml:id="_t5CcGnY">This approach may not limit variability in response, and substantial reduction in variability of treatment for subgroups in comparison to the group as a whole is far from assured.</s><s xml:id="_sn8aRR9">Even if variability is reduced, the average effect for that subgroup may not be representative of individual members of the subgroup.</s></p><p xml:id="_AFZKGKm"><s xml:id="_PQKja7f">SCEDs can identify the optimal treatment for an individual person rather than the average person in a group <ref type="bibr" target="#b12">(Dallery &amp; Raiff, 2014;</ref><ref type="bibr" target="#b13">Davidson et al., 2021;</ref><ref type="bibr" target="#b21">Hekler et al., 2020)</ref>.</s><s xml:id="_TSQyg9C">SCEDs are multiphase experimental designs in which a great deal of data is collected on a single person, said person serves as his or her own control <ref type="bibr" target="#b24">(Kazdin, 2011</ref><ref type="bibr" target="#b25">(Kazdin, , 2021))</ref>, and the order of presentation of conditions can be randomized to enhance experimental control.</s><s xml:id="_7qZVpFU">That is, a person's outcomes in one phase are compared to outcomes in another phase.</s><s xml:id="_XzEd9bM">In a typical study, replications are achieved within and/or across several individuals; this allows for strong inferences about causation between behavior and the treatment (or levels thereof).</s><s xml:id="_AsvXv3Q">Achieving replications is synonymous with achieving experimental control.</s></p><p xml:id="_5x2A7gR"><s xml:id="_dFxkzTu">We provide an overview of three experimental designs that can be adapted for personalized medicine: reversal, multiple baseline, and combined reversal and multiple baseline designs, and we discuss how SCEDs can be integrated into RCTs.</s><s xml:id="_enPy8bJ">These designs focus on demonstrating experimental control of the relationship between treatment and outcome.</s><s xml:id="_gn7rGhe">Several general principles common to all of the designs are noteworthy <ref type="bibr" target="#b36">(Lobo et al., 2017)</ref>.</s><s xml:id="_z853p8r">First, in many studies, treatment effects are compared with control conditions with a no-intervention baseline as the initial condition.</s><s xml:id="_e4MACjE">To reduce threats to internal validity of the study, the order of assignment of interventions can be randomized <ref type="bibr" target="#b28">(Kratochwill &amp; Levin, 2010)</ref> and, when possible, the intervention and data collection can be blinded.</s><s xml:id="_T9Vazfr">The demonstration of experimental control across conditions or people needs to be replicated several times (three replications is the minimum) to ensure confidence of the relationship between treatment and outcome <ref type="bibr" target="#b28">(Kratochwill et al., 2010;</ref><ref type="bibr" target="#b29">Kratochwill &amp; Levin, 2015)</ref>.</s><s xml:id="_SUThNVS">Demonstrating stability of data within a phase or, otherwise, no trend in the direction of treatment effects prior to starting treatment is particularly important.</s><s xml:id="_64PseMe">Stability refers to the degree of variability in the data path over time (e.g., data points must fall within a 15% range of the median for a condition).</s><s xml:id="_MdDJT3m">Thus, phase length needs to be flexible for the sake of determining stability and trend within a phase, but a minimum of 5 data points per phase has been recommended <ref type="bibr" target="#b30">(Kratochwill et al., 2013)</ref>.</s><s xml:id="_Dx4fr6K">The focus of the intervention's effects is on clinically rather than statistically significant effects with the target effect prespecified and considered in interpretation of the relevance of the effect for clinical practice <ref type="bibr" target="#b16">(Epstein et al., 2021)</ref>.</s><s xml:id="_vYvpKTx">In addition, multiple dependent outcomes can be simultaneously measured <ref type="bibr" target="#b16">(Epstein et al., 2021)</ref>.</s><s xml:id="_YGwCH3d">SCEDs can be used to test whether a variable mediates the effect of a treatment on symptoms or behavior <ref type="bibr" target="#b41">(Miočević et al., 2020;</ref><ref type="bibr" target="#b51">Riley &amp; Gaynor, 2014)</ref>.</s><s xml:id="_U7x2ys9">Visual inspection of graphical data is typically used to determine treatment effects, and statistical methods are commonly used to assist in interpretation of graphical data <ref type="bibr" target="#b16">(Epstein et al., 2021)</ref>.</s><s xml:id="_gFmAycA">Furthermore, a growing number of statistical approaches can summarize treatment effects and provide effect sizes <ref type="bibr" target="#b25">(Kazdin, 2021;</ref><ref type="bibr">Moeyaert &amp; Fingerhut, this issue;</ref><ref type="bibr" target="#b50">Pustejovsky, 2019;</ref><ref type="bibr" target="#b61">Shadish et al., 2014)</ref>.</s><s xml:id="_McS5yU6">Data across many SCED trials can be aggregated to assess the generality of the treatment effects to help address for whom and under what conditions an intervention is effective <ref type="bibr" target="#b5">(Branch &amp; Pennypacker, 2013;</ref><ref type="bibr" target="#b60">Shadish, 2014;</ref><ref type="bibr" target="#b65">Van den Noortgate &amp; Onghena, 2003)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2." xml:id="_fktpcus">Reversal Designs</head><p xml:id="_T4NRExp"><s xml:id="_cft93c6">A reversal design collects behavioral or biological outcome data in at least two phases: a baseline or notreatment phase (labeled as 'A') and the experimental or treatment phase (labeled as 'B').</s><s xml:id="_yUBbrVT">The design is called a reversal design because there must be reversals or replications of phases for each individual; for example, in an ABA design, the baseline phase is replicated <ref type="bibr" target="#b24">(Kazdin, 2011)</ref>.</s><s xml:id="_uTusx8S">Ideally, three replications of treatment effects are used to demonstrate experimental control <ref type="bibr" target="#b28">(Kratochwill et al., 2010;</ref><ref type="bibr" target="#b27">Kratochwill &amp; Levin, 1992)</ref>.</s><s xml:id="_7YEZNAb">Figure <ref type="figure" target="#fig_1">2</ref> Harvard Data Science Review • Special Issue 3: Personalized (N-of-1)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q4c8Vjn">Trials</head><p xml:id="_3x9Wx65"><s xml:id="_NVHvePh">The Family of Single-Case Experimental Designs 5</s></p><p xml:id="_dyK2w2P"><s xml:id="_UUuUFhD">shows hypothetical results from an A1B1A2B2 design.</s><s xml:id="_Kb4dTqC">The graph shows three replications of treatment effects (A1 versus B1, B1 versus A2, A2 versus B2) across four participants.</s><s xml:id="_YZ2PEWA">Each phase was carried out until stability was evident from visual inspection of the data as well as absence of trends in the direction of the desired effect.</s></p><p xml:id="_Nq5AX5X"><s xml:id="_5sbMBTZ">The replication across participants increases the confidence in the effectiveness of the intervention.</s><s xml:id="_KzBkcVT">Extension of this design is possible by comparing multiple interventions, as well.</s><s xml:id="_rpH67qp">The order of the treatments should be randomized, especially when the goal is to combine SCEDs across participants.</s></p><p xml:id="_uS3DCxD"><s xml:id="_WP3YBn9">Reversal designs can be more dynamic and compare several treatments.</s><s xml:id="_ZFR9VS8">A common approach in personalized medicine would be to compare two or more doses of or different components of the same treatment (Ward-</s></p><p xml:id="_fc5nswq"><s xml:id="_93V66Kb">Horner &amp; Sturmey, 2010).</s><s xml:id="_ezk2PP3">For example, two drug doses could be compared using an A1B1C1B2C2 design,</s></p><p xml:id="_s5RVyPq"><s xml:id="_V8W9sjq">where A represents placebo and B and C represent the different drug doses <ref type="bibr" target="#b18">(Guyatt et al., 1990)</ref>.</s><s xml:id="_Xh6bdmv">In the case of drug studies, the drug/placebo administration can be double blinded.</s><s xml:id="_3NMxXxy">A more complex design could be A1B1A2C1A3C2A4B2, which would yield multiple replications of the comparison between drug and placebo.</s></p><p xml:id="_znsmpMv"><s xml:id="_4tfH4sa">Based on the kinetics of the drug and the need for a washout period, the design could also be A1B1C1B2C2.</s><s xml:id="_k8rQQb7">This would provide three demonstration of treatment effects: B1 to C1, C1 to B2, and B2 to C2.</s><s xml:id="_FMbhAPn">Other permutations could be planned strategically to identify the optimal dose for each individual.</s></p><p xml:id="_phXREKw"><s xml:id="_QneKCMh">Advantages of SCED reversal designs are their ability to experimentally show that a particular treatment was functionally related to a particular change in an outcome variable for that person.</s><s xml:id="_uATGJPy">This is the core principle of personalized medicine: an optimal treatment for an individual can be identified <ref type="bibr" target="#b12">(Dallery &amp; Raiff, 2014;</ref><ref type="bibr" target="#b13">Davidson et al., 2021;</ref><ref type="bibr" target="#b18">Guyatt et al., 1990;</ref><ref type="bibr" target="#b21">Hekler et al., 2020;</ref><ref type="bibr" target="#b35">Lillie et al., 2011)</ref>.</s><s xml:id="_FXPNpQs">These designs can work well for studying the effect of interventions on rare diseases in which collecting enough participants with similar characteristics for an RCT would be unlikely.</s><s xml:id="_3q7agks">An additional strength is the opportunity for the clinical researcher who also delivers clinical care to translate basic science findings or new findings from RCTs to their patients, who can potentially benefit <ref type="bibr" target="#b12">(Dallery &amp; Raiff, 2014;</ref><ref type="bibr" target="#b20">Hayes, 1981)</ref>.</s><s xml:id="_Y2JrGZx">Research suggests that the trickledown of new developments and hypotheses to their support in RCTs can take more than 15 years; many important advancements in the medical and behavior sciences are likely not to be implemented rapidly enough <ref type="bibr" target="#b52">(Riley et al., 2013)</ref>.</s><s xml:id="_Ym9gThG">The ability to test new intervention developments using scientific principles could speed up their translation into practice.</s></p><p xml:id="_mnT6Gnp"><s xml:id="_2zK7wHa">Limitations to SCED designs, however, are worth noting.</s><s xml:id="_xmAwPTZ">Firstly, in line with the expectation that the outcome returns to baseline levels, reversals may require removal of the treatment.</s><s xml:id="_fHJZ43x">If the effect is not quickly reversible, then the designs are not relevant.</s><s xml:id="_mwXNVE5">A washout period may be placed in-between phases if the effect is not immediately reversible; for example, a drug washout period could be planned based on the half-life of drug.</s></p><p xml:id="_NqkxWgV"><s xml:id="_xmYycyB">Secondly, the intervention should have a relatively immediate effect on the outcome.</s><s xml:id="_DCj8vqt">If many weeks to months are needed for some interventions to show effects, a reversal design may not be optimal unless the investigator is willing to plan a lengthy study.</s><s xml:id="_EykMSrw">Thirdly, the design depends on comparing stable data over conditions.</s><s xml:id="_xdFCqwz">If achieving stability due to uncontrolled sources of biological or environmental variation is not possible, a reversal design may not be appropriate to evaluate a treatment, though it may be useful to identify the sources of variability <ref type="bibr" target="#b62">(Sidman, 1960)</ref>.</s><s xml:id="_CgM8Yak">Finally, for a reversal to a baseline, a no-treatment phase may be inappropriate in investigating treatment effects for a very ill patient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3." xml:id="_9G9pn6R">Multiple Baseline Designs</head><p xml:id="_BWXcMcw"><s xml:id="_zwncgCb">An alternative to a reversal design is the multiple baseline design, which does not require reversal of conditions to establish experimental control.</s><s xml:id="_swAAJWK">There are three types of multiple baseline designs: multiple baseline across people, behaviors, and settings.</s><s xml:id="_RcZtJUn">The most popular is the multiple baseline across people, in which baselines are established for three or more people for the same outcome <ref type="bibr" target="#b9">(Cushing et al., 2011;</ref><ref type="bibr" target="#b40">Meredith et al., 2011)</ref>.</s></p><p xml:id="_CUQybhY"><s xml:id="_cgTYTG8">Treatment is implemented after different durations of baseline across individuals.</s><s xml:id="_BJBpYCK">The order of treatment implementation across people can be randomized <ref type="bibr" target="#b72">(Wen et al., 2019)</ref>.</s><s xml:id="_Qz4PnHU">Figure <ref type="figure" target="#fig_2">3</ref> shows an example across three individuals.</s><s xml:id="_DaPDRKS">In this hypothetical example, baseline data for each person are relatively stable and not decreasing, and reductions in the dependent variable are only observed after introduction of the intervention.</s><s xml:id="_n6rsW2B">Inclusion of one control person, who remains in baseline throughout the study and provides a control for extended monitoring, is also possible.</s><s xml:id="_aHpudqu">Another variation is to collect baseline data intermittently in a 'probe' design, which can minimize burden associated with simultaneous and repeated measurement of outcomes <ref type="bibr" target="#b7">(Byiers et al., 2012;</ref><ref type="bibr" target="#b22">Horner &amp; Baer, 1978)</ref>.</s><s xml:id="_jVexU2h">If the outcomes do not change during baseline conditions and the changes only occur across participants after the treatment has been implemented-and this sequence is replicated across several people-change in the outcome may be safely attributed to the treatment.</s><s xml:id="_w43pDav">The length of the baselines still must be long enough to show stability and no trend toward improvement until the treatment is implemented.</s></p><p xml:id="_CUGtQhH"><s xml:id="_BrQf54x">The two other multiple baseline designs focus on individual people: the multiple baseline across settings and the multiple baseline across behaviors <ref type="bibr" target="#b3">(Boles et al., 2008;</ref><ref type="bibr" target="#b34">Lane-Brown &amp; Tate, 2010)</ref>.</s><s xml:id="_p9yw6pT">An example of a multiple baseline across settings would be a dietary intervention implemented across meals.</s><s xml:id="_DZZEeJs">An intervention that targets a reduction in consumption of high-glycemic index foods, or foods with added sugar across meals, could be developed with the order of meals randomized.</s><s xml:id="_JrhZb28">For example, someone may be randomized to reduce sugar-added or high-glycemic index foods for breakfast without any implementation at lunch or dinner.</s></p><p xml:id="_HJvgsj7"><s xml:id="_Py2ZYn9">Implementation of the diet at lunch and then dinner would occur after different durations of baselines in these</s></p><p xml:id="_Xp2WQ2n"><s xml:id="_sa9UMg2">settings.</s><s xml:id="_aEXCC9m">An example of multiple baseline across behaviors might be to use feedback to develop a comprehensive exercise program that involves stretching, aerobic exercise, and resistance training.</s><s xml:id="_hhJ4JjC">Feedback could target improvement in one of these randomly selected behaviors, implemented in a staggered manner.</s></p><p xml:id="_3N32eZd"><s xml:id="_v3TbxNJ">The main limitation to a multiple baseline design is that some people (or behaviors) may be kept in baseline or control conditions for extended periods before treatment is implemented.</s><s xml:id="_BnMwZkn">Of course, failure to receive an effective treatment is common in RCTs for people who are randomized to control conditions, but unlike control groups in RCTs, all participants eventually receive treatment.</s></p><p xml:id="_GvjJYs3"><s xml:id="_sjtYrbB">Finally, while the emphasis in personalized medicine is the identification of an optimal treatment plan for an individual person, situations in which multiple baselines across people prove relevant for precision medicine may arise.</s><s xml:id="_hBwYbdc">For example, identification of a small group of people with common characteristics-perhaps with a rare disease and for which a multiple-baseline-across-people design could be used to test an intervention more effectively than a series of personalized designs-is possible.</s><s xml:id="_UVQdj5P">In a similar vein, differential response to a common treatment in a multiple-baseline-across-people design can help to identify individual differences that can compromise the response to a treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4." xml:id="_b3kmyVj">Integrating Multiple Baseline and Reversal Designs</head><p xml:id="_vrtQBnF"><s xml:id="_cVr8Fpt">While reversal designs can be used to compare effects of interventions, multiple baseline designs provide experimental control for testing one intervention but do not compare different interventions.</s><s xml:id="_CDU6r3h">One way to take advantage of the strengths of both designs is to combine them.</s><s xml:id="_vCHFX4V">For example, the effects of a first treatment could be studied using a multiple-baseline format and, after experimental control has been established, return to baseline prior to the commencement of a different treatment, which may be introduced in a different order.</s></p><p xml:id="_mkfvCw2"><s xml:id="_SpNWDy8">These comparisons can be made for several different interventions with the combination of both designs to demonstrate experimental control and compare effects of the interventions.</s></p><p xml:id="_T6HSVFX"><s xml:id="_SvnEbHu">Figure <ref type="figure" target="#fig_4">4</ref> shows a hypothetical example of a combined approach to identify the best drug to decrease blood pressure.</s><s xml:id="_hBNS6c8">Baseline blood pressures are established for three people under placebo conditions before new drug X is introduced across participants in a staggered fashion to establish relative changes in blood pressure.</s><s xml:id="_v8UGPma">All</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5." xml:id="_9CYCNjW">Other Varieties of Single-Case Experimental Designs</head><p xml:id="_yXbwjgA"><s xml:id="_3Cd4Hsh">Other less commonly used designs within the family of SCEDs may be useful for personalized medicine.</s><s xml:id="_usCZg5z">One of the most relevant may be the alternating treatment design <ref type="bibr" target="#b1">(Barlow &amp; Hayes, 1979;</ref><ref type="bibr" target="#b38">Manolov et al., 2021)</ref>, in which people are exposed to baseline and one or more treatments for very brief periods without the concern about stability before changing conditions.</s><s xml:id="_Tay2Zrx">While the treatment period may be short, many more replications of treatments-and ineffective treatments-can be identified quickly.</s><s xml:id="_BCuWDD9">This type of design may be relevant for drugs that have rapid effects with a short half-life and behavioral interventions that have rapid effects <ref type="bibr" target="#b8">(Coyle &amp; Robertson, 1998)</ref>-for example, the effects of biofeedback on heart rate <ref type="bibr" target="#b71">(Weems, 1998)</ref>.</s><s xml:id="_NCBZQmZ">Another design is the changing criterion design, in which experimental control is demonstrated when the outcome meets certain preselected criteria that can be systematically increased or decreased over time <ref type="bibr" target="#b19">(Hartmann &amp; Hall, 1976</ref>).</s><s xml:id="_j9dsSDG">The design is especially useful when learning a new skill or when outcomes change slowly over time <ref type="bibr" target="#b63">(Singh &amp; Leung, 1988)</ref>-for example, gradually increasing the range of foods chosen in a previously highly selective eater <ref type="bibr" target="#b54">(Russo et al., 2019)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6." xml:id="_xASebxy">Integrating Single-Case Experimental Designs Into Randomized Controlled Trials</head><p xml:id="_5bScd4W"><s xml:id="_cKsJjB6">SCEDs can be integrated into RCTs to compare the efficacy of treatments chosen for someone based on SCEDs versus a standardized or usual care treatment <ref type="bibr" target="#b16">(Epstein et al., 2021;</ref><ref type="bibr" target="#b58">Schork &amp; Goetz, 2017)</ref>.</s><s xml:id="_eRWjBCM">Such innovative designs may capture the best in SCEDs and randomized controlled designs.</s><s xml:id="_6NqMmU2"><ref type="bibr" target="#b33">Kravitz et al. (2018)</ref> used an RCT in which one group (n = 108) experienced a series of reversal AB conditions, or a personalized (N-of-1) trial.</s><s xml:id="_TkCRGCS">The specific conditions were chosen for each patient from among eight categories of treatments to reduce chronic musculoskeletal pain (e.g., acetaminophen, any nonsteroidal anti-inflammatory drug, acetaminophen/oxycodone, tramadol).</s><s xml:id="_c9VUCJH">The other group (n = 107) received usual care.</s><s xml:id="_gWfTdWP">The study also incorporated mobile technology to record pain-related data daily (see <ref type="bibr" target="#b11">Dallery et al., 2013</ref>, for a discussion of technology and SCEDs).</s><s xml:id="_sXGJgPx">The results suggested that the N-of-1 approach was feasible and acceptable, but it did not yield statistically significant superior results in pain measures compared to the usual care group.</s><s xml:id="_b6hSRFt">However, as noted by <ref type="bibr" target="#b68">Vohra and Punja (2019)</ref>, the results do not indicate a flaw in the methodological approach: finding that two treatments do not differ in superiority is a finding worth knowing.</s></p><p xml:id="_2Aw27VU"><s xml:id="_bVqhzhc">Another example of a situation where an integrated approach may be useful is selecting a diet for weight control.</s><s xml:id="_wwpC25m">Many diets for weight control that vary in their macronutrient intake-such as low carb, higher fat versus low fat, and higher carb-have their proponents and favorable biological mechanisms.</s><s xml:id="_MteGfe8">However, direct comparisons of these diets basically show that they achieve similar weight control with large variability in outcome.</s><s xml:id="_Fq6Njj8">Thus, while the average person on a low-fat diet does about the same as the average person on a lowcarb diet, some people on the low-carb diet do very well, while some fail.</s><s xml:id="_WQ8dJP2">Some of the people who fail on the low-fat diet would undoubtedly do well on the low-carb diet, and some who fail on the low-fat diet would do well on the low-carb diet.</s><s xml:id="_cePw9FP">Further, some would fail on both diets due to general problems in adherence.</s></p><p xml:id="_eYXwbM8"><s xml:id="_XF22XNZ">Harvard Data Science Review • Special Issue 3: Personalized (N-of-1)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dvvreJf">Trials</head><p xml:id="_cMY3JQc"><s xml:id="_ejgdFVS">The Family of Single-Case Experimental Designs 13</s></p><p xml:id="_TykKDvF"><s xml:id="_NmCNtsc">Personalized medicine suggests that diets should be individualized to achieve the best results.</s><s xml:id="_W35JYHJ">SCEDs would be one way to show 'proof of concept' that a particular diet is better than a standard healthy diet.</s><s xml:id="_XauwQrf">First, people would be randomized to experimental (including SCEDs) or control (not basing diet on SCEDs).</s><s xml:id="_hsctEHS">Subject selection criteria would proceed as in any RCT.</s><s xml:id="_kpbyUJu">For the first 3 months, people in the experimental group would engage in individual reversal designs in which 2-week intervals of low-carb and low-fat diets would be interspersed with their usual eating, and weight loss, diet adherence, food preferences, and the reinforcing value of foods in the diet would be measured to assess biological, behavioral, and subjective changes.</s></p><p xml:id="_P4WPrph"><s xml:id="_UkdMeSN">Participants in the control group would experience a similar exposure to the different types of diets, but the diet to which they are assigned would be randomly chosen rather than chosen using SCED methods.</s><s xml:id="_msQBjNE">In this way, they would have similar exposure to diets during the first 3 months of the study, but this experience would not impact group assignment.</s><s xml:id="_jPQhgT8">As with any RCT, the study would proceed with regular measures (e.g., 6, 12, 24 months) and the hypothesis that those assigned to a diet that results in better initial weight loss, and that they like and are motivated to continue, would do better than those receiving a randomly selected diet.</s><s xml:id="_TPs3AkY">The study could also be designed with three groups: a single-case design experimental group similar to the approach in the hypothetical study above and two control groups, one low-fat and one low-carb.</s></p><p xml:id="_Mz9895z"><s xml:id="_fdprVT7">An alternative design would be to have everyone experience SCEDs for the first 3 months and then be randomized to either the optimal treatment identified during the first 3 months or an intervention randomly chosen among the interventions to be studied.</s><s xml:id="_MZcgNNw">This design has the advantage of randomization being after 3 months of study so that dropouts and nonadherers within the first 3 months would not be randomized in an intent-to-treat format.</s></p><p xml:id="_Whbm8TP"><s xml:id="_hPxpXpN">The goal of either hypothesized study, or any study that attempts to incorporate SCEDs into RCTs, is that matching participants to treatments will provide superior results in comparison to providing the same treatment to everyone in a group.</s><s xml:id="_PvsTYMB">Two hypotheses can be generated in these types of designs: first, that the mean changes will differ between groups, and second, that the variability will differ between groups with less variability in outcome for people who have treatment selected after a single-case trial than people who have a treatment randomly selected.</s><s xml:id="_c6GphBT">A reduction in variability plus mean differences in outcome should increase the effect size for people treated using individualized designs, increase power, and allow for a smaller sample size to ensure confidence about the differences observed between groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7." xml:id="_5t9V6yZ">Limitations of Single-Case Experimental Designs</head><p xml:id="_MEMT8YR"><s xml:id="_YB8HCwB">Single-case experimental designs have their common limitations.</s><s xml:id="_VfpxMBM">If a measure changes with repeated testing without intervention, it may not be useful for an SCED unless steps can be taken to mitigate such reactivity, such as more unobtrusive monitoring <ref type="bibr" target="#b25">(Kazdin, 2021)</ref>.</s><s xml:id="_H9zBWW6">Given that the effects of interventions are evaluated over time, systematic environmental changes or maturation could influence the relationship between a treatment and outcome and thereby obscure the effect of a treatment.</s><s xml:id="_9EtCR2e">However, the design logic of reversal and multiple</s></p><p xml:id="_NJTmkYP"><s xml:id="_ASgfp6V">Harvard Data Science Review • Special Issue 3: Personalized (N-of-1)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uCJgkxE">Trials</head><p xml:id="_5y5Zb4C"><s xml:id="_HnHUz3x">The Family of Single-Case Experimental Designs baseline designs largely control for such influences.</s><s xml:id="_3CCCu2A">Since SCEDs rely on repeated measures and a detailed study of the relationship between treatment and outcome, studies that use dependent measures that cannot be sampled frequently are not candidates for SCEDs.</s><s xml:id="_Ewwzz8Y">Likewise, the failure to identify a temporal relationship between the introduction of treatment and initiation of change in the outcome can make attribution of changes to the intervention challenging.</s><s xml:id="_xFjr684">A confounding variable's association with introduction or removal of the intervention, which may cause inappropriate decisions about the effects of the intervention, is always possible.</s></p><p xml:id="_mckQrMH"><s xml:id="_NfFvBt7">Dropout or uncontrolled events that occur to individuals can introduce confounding variables to the SCED.</s></p><p xml:id="_v8GzZjt"><s xml:id="_Z7T8Dd5">These problems are not unique to SCEDs and also occur with RCTs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8." xml:id="_WwVrfZf">Single-Case Experimental Designs in Early Stage Translational Research</head><p xml:id="_TwT542P"><s xml:id="_GZTG3ET">The emphasis of a research program may be on translating basic science findings to clinical interventions.</s><s xml:id="_2hXGbtY">The goal may be to collect early phase translational research as a step toward a fully powered RCT- <ref type="bibr" target="#b16">(Epstein et al., 2021)</ref>.</s><s xml:id="_48RbmeH">The fact that a large amount of basic science does not get translated into clinical interventions is well known <ref type="bibr" target="#b6">(Butler, 2008;</ref><ref type="bibr" target="#b59">Seyhan, 2019)</ref>; this served in part as the stimulus for the National Institutes of Health (NIH) to develop a network of clinical and translational science institutes in medical schools and universities throughout the United States.</s><s xml:id="_AdCMrrU">A common approach to early phase translational research is to implement a small, underpowered RCT to secure a 'signal' of a treatment effect and an effect size.</s><s xml:id="_2AcztUg">This is a problematic approach to pilot research, and it is not advocated by the NIH as an approach to early phase translational research (National Center for Complementary and Integrative Health, 2020).</s><s xml:id="_yTk32MR">The number of participants needed for a fully powered RCT may be substantially different from the number projected from a small-sample RCT.</s><s xml:id="_zwrJArm">These small, underpowered, early phase translational studies may provide too large an estimate of an effect size, leading to an underpowered RCT.</s><s xml:id="_4yrZhHx">Likewise, a small-sample RCT can lead to a small effect size that can, in turn, lead to a failure to implement a potentially effective intervention <ref type="bibr" target="#b26">(Kraemer et al., 2006)</ref>.</s><s xml:id="_4uhspFk">Therefore, SCEDs-especially reversal and multiple baseline designs-are evidently ideally suited to early phase translational research.</s><s xml:id="_j7jUjkg">This use complements the utility of SCEDs for identifying the optimal treatment for an individual or small group of individuals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9." xml:id="_VUMA92f">Conclusion</head><p xml:id="_t2ETEaK"><s xml:id="_EzXyUFa">Single-case experimental designs provide flexible, rigorous, and cost-effective approaches that can be used in personalized medicine to identify the optimal treatment for an individual patient.</s><s xml:id="_kjsdheB">SCEDs represent a broad array of designs, and personalized (N-of-1) designs are a prominent example, particularly in medicine.</s><s xml:id="_ZkKv9Bt">These designs can be incorporated into RCTs, and they can be integrated using meta-analysis techniques.</s><s xml:id="_UePK9hP">SCEDs should become a standard part of the toolbox for clinical researchers to improve clinical care for their patients, and they can lead to the next generation of interventions that show maximal effects for individual cases as well as for early phase translational research to clinical practice.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_kAfMfym"><s xml:id="_wxTgh86">Figure 1.</s><s xml:id="_KA7aQz2">The main family of single-case experimental designs and nonexperimental designs.</s><s xml:id="_E7keznG">A = Baseline, B and C refer to different treatments.</s></p></div></figDesc><graphic coords="3,72.00,237.75,468.00,139.50" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_aHZEXxM"><s xml:id="_Ak6E9b5">Figure 2. Example of a reversal design showing replications within and between subjects.</s><s xml:id="_cMHuJNu">A1 = First Baseline, B1 First Treatment, A2 = Return to Baseline, B2 = Return to Treatment.</s><s xml:id="_2UVkTkw">P1-P4 represent different hypothetical participants.</s></p></div></figDesc><graphic coords="5,72.00,186.00,468.00,329.25" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_dqth8GX"><s xml:id="_ZvBAYBt">Figure 3. Example of a multiple baseline design showing replications between subjects.</s><s xml:id="_nCknTGT">P1-P3 represent different hypothetical participants.</s></p></div></figDesc><graphic coords="8,144.75,72.00,322.50,558.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><figDesc><div><p xml:id="_hveXyBX"><s xml:id="_dZ5xxXB">return to placebo after blood pressures reach stability, drug Y is introduced in a staggered sequence, participants are returned to placebo, and the most effective intervention for each individual (drug X or Y) is reintroduced to replicate the most important result: the most effective medication.</s><s xml:id="_YkbeJhW">This across-subjects design establishes experimental control for two different new drug interventions across three people while also Harvard Data Science Review • Special Issue 3: Personalized (N-of-1)TrialsThe Family of Single-Case Experimental Designs 10 establishing experimental control for five comparisons within subjects (placebo-drug X, drug Y-placebo, placebo-drug Y, drug Y-placebo, placebo-more effective drug).</s><s xml:id="_zPQBGNm">Though this combined design strengthens confidence beyond either reversal or multiple baseline designs, in many situations, experimental control demonstrated using a reversal design is sufficient.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc><div><p xml:id="_VEfEt6t"><s xml:id="_fjV3bHD">Figure 4. Example of a combined reversal and multiple baseline to determine the best drug to lower blood pressure.</s><s xml:id="_QpkR9Tv">BL = Baseline.</s><s xml:id="_WpmNme2">Drug X and Drug Y represent hypothetical drugs to lower blood pressure, and Best Drug represents a reversal to the most effective drug as identified for each hypothetical participant, labeled P1-P3.</s></p></div></figDesc><graphic coords="11,95.25,72.00,421.50,531.00" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_PSGvR9E">Acknowledgments</head><p xml:id="_eNbsXrz"><s xml:id="_EAw4AsY">We thank <rs type="person">Lesleigh Stinson</rs> and <rs type="person">Andrea Villegas</rs> for preparing the figures.</s></p></div>
<div><head xml:id="_XJ95H2n">Disclosure Statement</head><p xml:id="_9A3VxBV"><s xml:id="_t7p4zXy">Preparation of this special issue was supported by grants <rs type="grantNumber">R01LM012836</rs> from the <rs type="funder">National Library of Medicine of the National Institutes of Health</rs> and <rs type="grantNumber">P30AG063786</rs> from the <rs type="funder">National Institute on Aging of the National Institutes of Health</rs>.</s><s xml:id="_ETkd82B">Funding to authors of this article was supported by grants <rs type="grantNumber">U01 HL131552</rs> from the <rs type="funder">National Heart, Lung, and Blood Institute</rs>, <rs type="grantNumber">UH3 DK109543</rs> from the <rs type="funder">National Institute of Diabetes, Digestive and Kidney Diseases</rs>, and <rs type="grantNumber">RO1HD080292</rs> and <rs type="grantNumber">RO1HD088131</rs> from the <rs type="funder">Eunice Kennedy Shriver National Institute of Child Health and Human Development</rs>.</s><s xml:id="_NQ8Ctv8">The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.</s><s xml:id="_FE6yP8j">The views expressed in this paper are those of the authors and do not represent the views of the <rs type="institution">National Institutes of Health</rs>, the <rs type="institution">U.S. Department of Health and Human Services</rs>, or any other government entity.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_rGQm8wD">
					<idno type="grant-number">R01LM012836</idno>
				</org>
				<org type="funding" xml:id="_GA7ufnh">
					<idno type="grant-number">P30AG063786</idno>
				</org>
				<org type="funding" xml:id="_MYwfnbp">
					<idno type="grant-number">U01 HL131552</idno>
				</org>
				<org type="funding" xml:id="_5vHyqxb">
					<idno type="grant-number">UH3 DK109543</idno>
				</org>
				<org type="funding" xml:id="_kUh9pSn">
					<idno type="grant-number">RO1HD080292</idno>
				</org>
				<org type="funding" xml:id="_8jUcn7A">
					<idno type="grant-number">RO1HD088131</idno>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_BsJNXNh">Alternative designs for clinical trials in rare diseases</title>
		<author>
			<persName><forename type="first">L</forename><surname>Abrahamyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Faughnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Diamond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.c.31533</idno>
		<ptr target="https://doi.org/10.1002/ajmg.c.31533" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_EE399Zy">American Journal of Medical Genetics, Part C: Seminars in Medical Genetics</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="313" to="331" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abrahamyan, L., Feldman, B. M., Tomlinson, G., Faughnan, M. E., Johnson, S. R., Diamond, I. R., &amp; Gupta, S. (2016). Alternative designs for clinical trials in rare diseases. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 172(4), 313-331. https://doi.org/10.1002/ajmg.c.31533</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_jsue3Xz">Alternating treatments design: One strategy for comparing the effects of two treatments in a single subject</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Barlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hayes</surname></persName>
		</author>
		<idno type="DOI">10.1901/jaba.1979.12-199</idno>
		<ptr target="https://doi.org/10.1901/jaba.1979.12-199" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BpX4ppY">Journal of Applied Behavior Analysis</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="199" to="210" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barlow, D. H., &amp; Hayes, S. C. (1979). Alternating treatments design: One strategy for comparing the effects of two treatments in a single subject. Journal of Applied Behavior Analysis, 12(2), 199-210. https://doi.org/10.1901/jaba.1979.12-199</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_vUPzS7t">The value of interrupted time-series experiments for community intervention research</title>
		<author>
			<persName><forename type="first">A</forename><surname>Biglan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Wagenaar</surname></persName>
		</author>
		<idno type="DOI">10.1023/a:1010024016308</idno>
		<ptr target="https://doi.org/10.1023/a:1010024016308" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XU3ERzX">Prevention Science</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="31" to="49" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Biglan, A., Ary, D., &amp; Wagenaar, A. C. (2000). The value of interrupted time-series experiments for community intervention research. Prevention Science, 1(1), 31-49. https://doi.org/10.1023/a:1010024016308</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_ukuunwW">Treating non-retentive encopresis with rewarded scheduled toilet visits</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Boles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Vernberg</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf03391730</idno>
		<ptr target="https://doi.org/10.1007/bf03391730" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_f832p27">Behavior Analysis in Practice</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="68" to="72" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boles, R. E., Roberts, M. C., &amp; Vernberg, E. M. (2008). Treating non-retentive encopresis with rewarded scheduled toilet visits. Behavior Analysis in Practice, 1(2), 68-72. https://doi.org/10.1007/bf03391730</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Boring</surname></persName>
		</author>
		<title level="m" xml:id="_tuat4eq">A history of experimental psychology</title>
		<imprint>
			<publisher>Appleton-Century-Crofts</publisher>
			<date type="published" when="1929">1929</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boring, E. G. (1929). A history of experimental psychology. Appleton-Century-Crofts.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_sngs9tv">Generality and generalization of research findings</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Branch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Pennypacker</surname></persName>
		</author>
		<idno type="DOI">10.1037/13937-007</idno>
		<ptr target="https://doi.org/10.1037/13937-007HarvardData" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_CgMGnCr">APA handbook of behavior analysis</title>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Madden</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">V</forename><surname>Dube</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Hackenberg</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Hanley</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">K</forename><forename type="middle">A</forename></persName>
		</editor>
		<imprint>
			<publisher>American Psychological Association</publisher>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="151" to="175" />
		</imprint>
	</monogr>
	<note>Special Issue 3: Personalized (N-of-1) Trials The Family of Single-Case Experimental Designs 16</note>
	<note type="raw_reference">Branch, M. N., &amp; Pennypacker, H. S. (2013). Generality and generalization of research findings. In G. J. Madden, W. V. Dube, T. D. Hackenberg, G. P. Hanley, &amp; K. A. Lattal (Eds.), APA handbook of behavior analysis, Vol. 1. Methods and principles (pp. 151-175). American Psychological Association. https://doi.org/10.1037/13937-007 Harvard Data Science Review • Special Issue 3: Personalized (N-of-1) Trials The Family of Single-Case Experimental Designs 16</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_enAmTwZ">Translational research: Crossing the valley of death</title>
		<author>
			<persName><forename type="first">D</forename><surname>Butler</surname></persName>
		</author>
		<idno type="DOI">10.1038/453840a</idno>
		<ptr target="https://doi.org/10.1038/453840a" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_B6aBYkf">Nature</title>
		<imprint>
			<biblScope unit="volume">453</biblScope>
			<biblScope unit="issue">7197</biblScope>
			<biblScope unit="page" from="840" to="842" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Butler D. (2008). Translational research: Crossing the valley of death. Nature, 453(7197), 840-842. https://doi.org/10.1038/453840a</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_2G9ZFrU">Single-subject experimental design for evidence-based practice</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Byiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reichle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Symons</surname></persName>
		</author>
		<idno type="DOI">10.1044/1058-0360(2012/11-0036</idno>
		<ptr target="https://doi.org/10.1044/1058-0360(2012/11-0036" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BXJGP3Z">American Journal of Speech-Language Pathology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="397" to="414" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Byiers, B. J., Reichle, J., &amp; Symons, F. J. (2012). Single-subject experimental design for evidence-based practice. American Journal of Speech-Language Pathology, 21(4), 397-414. https://doi.org/10.1044/1058- 0360(2012/11-0036)</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_x3hY5FR">Comparison of two passive mobilizing techniques following Colles&apos; fracture: A multi-element design</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Coyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Robertson</surname></persName>
		</author>
		<idno type="DOI">10.1054/math.1998.0314</idno>
		<ptr target="https://doi.org/10.1054/math.1998.0314" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pSanS6K">Manual Therapy</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="41" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Coyle, J. A., &amp; Robertson, V. J. (1998). Comparison of two passive mobilizing techniques following Colles&apos; fracture: A multi-element design. Manual Therapy, 3(1), 34-41. https://doi.org/10.1054/math.1998.0314</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_nG4vKtM">An evaluation of a personal electronic device to enhance self-monitoring adherence in a pediatric weight management program using a multiple baseline design</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Cushing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Steele</surname></persName>
		</author>
		<idno type="DOI">10.1093/jpepsy/jsq074</idno>
		<ptr target="https://doi.org/10.1093/jpepsy/jsq074" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MPbapmt">Journal of Pediatric Psychology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="301" to="307" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cushing, C. C., Jensen, C. D., &amp; Steele, R. G. (2011). An evaluation of a personal electronic device to enhance self-monitoring adherence in a pediatric weight management program using a multiple baseline design. Journal of Pediatric Psychology, 36(3), 301-307. https://doi.org/10.1093/jpepsy/jsq074</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_h9zRnFx">From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Czajkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naar-King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laraia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Olster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Perna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Epel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Boyington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Charlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Related</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Czajkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Boyington</surname></persName>
		</author>
		<idno type="DOI">10.1037/hea0000161</idno>
		<ptr target="https://doi.org/10.1037/hea0000161" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_THKaqr5">Health Psychology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="971" to="982" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Czajkowski, S. M., Powell, L. H., Adler, N., Naar-king, S., Reynolds, K. D., Hunter, C. M., Laraia, B., Olster, D. H., Perna, F. M., Peterson, J. C., Epel, E., Boyington, J. E., Charlson, M. E., Related, O., Czajkowski, S. M., Powell, L. H., Adler, N., Reynolds, K. D., Hunter, C. M., … Boyington, J. E. (2015). From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychology, 34(10), 971- 982. https://doi.org/10.1037/hea0000161</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_NtH6rpP">Single-case experimental designs to evaluate novel technology-based health interventions</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dallery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Cassidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Raiff</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.2227</idno>
		<ptr target="https://doi.org/10.2196/jmir.2227" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ASHkmPu">Journal of Medical Internet Research</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dallery, J., Cassidy, R. N., &amp; Raiff, B. R. (2013). Single-case experimental designs to evaluate novel technology-based health interventions. Journal of Medical Internet Research, 15(2), Article e22. https://doi.org/10.2196/jmir.2227</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_kJnB9cK">Optimizing behavioral health interventions with single-case designs: From development to dissemination</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dallery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Raiff</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13142-014-0258-z</idno>
		<ptr target="https://doi.org/10.1007/s13142-014-0258-z" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pq3URer">Translational Behavioral Medicine</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="290" to="303" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dallery, J., &amp; Raiff, B. R. (2014). Optimizing behavioral health interventions with single-case designs: From development to dissemination. Translational Behavioral Medicine, 4(3), 290-303. https://doi.org/10.1007/s13142-014-0258-z</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_Xu32sNq">Experimental designs to optimize treatments for individuals</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Silverstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Paluch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamapediatrics.2020.5801</idno>
		<ptr target="https://doi.org/10.1001/jamapediatrics.2020.5801" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PC7F4q4">JAMA Pediatrics</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="404" to="409" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Davidson, K. W., Silverstein, M., Cheung, K., Paluch, R. A., &amp; Epstein, L. H. (2021). Experimental designs to optimize treatments for individuals. JAMA Pediatrics, 175(4), 404-409. https://doi.org/10.1001/jamapediatrics.2020.5801</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_KgBxqA4">Single-patient (n-of-1) trials: A pragmatic clinical decision methodology for patient-centered comparative effectiveness research</title>
		<author>
			<persName><forename type="first">N</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kravitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2013.04.006</idno>
		<ptr target="https://doi.org/10.1016/j.jclinepi.2013.04.006" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xa87FH2">Journal of Clinical Epidemiology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="21" to="S28" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Duan, N., Kravitz, R. L., &amp; Schmid, C. H. (2013). Single-patient (n-of-1) trials: A pragmatic clinical decision methodology for patient-centered comparative effectiveness research. Journal of Clinical Epidemiology, 66(8 Suppl), S21-S28. https://doi.org/10.1016/j.jclinepi.2013.04.006</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main" xml:id="_TqJuNCw">Memory; A contribution to experimental psychology</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ebbinghaus</surname></persName>
		</author>
		<idno type="DOI">10.1037/10011-000</idno>
		<imprint>
			<date type="published" when="1913">1913</date>
		</imprint>
		<respStmt>
			<orgName>Teachers College, Columbia University</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Ebbinghaus, H. (1913). Memory; A contribution to experimental psychology. Teachers College, Columbia University.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_hqnucgk">Single case designs for early phase behavioral translational research in health psychology</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Bickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Czajkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Paluch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moeyaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Davidson</surname></persName>
		</author>
		<idno type="DOI">10.1037/hea0001055</idno>
		<ptr target="https://doi.org/10.1037/hea0001055" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_m6aKedR">Health Psychology</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="858" to="874" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Epstein, L. H., Bickel, W. K., Czajkowski, S. M., Paluch, R. A., Moeyaert, M., &amp; Davidson, K. W. (2021). Single case designs for early phase behavioral translational research in health psychology. Health Psychology, 40(12), 858-874. https://doi.org/10.1037/hea0001055</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_gbECrU5">Lack of group-to-individual generalizability is a threat to human subjects research</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Medaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Jeronimus</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1711978115</idno>
		<ptr target="https://doi.org/10.1073/pnas.1711978115" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RxyGpT7">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="6106" to="E6115" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fisher, A. J., Medaglia, J. D., &amp; Jeronimus, B. F. (2018). Lack of group-to-individual generalizability is a threat to human subjects research. Proceedings of the National Academy of Sciences of the United States of America, 115(27), E6106-E6115. https://doi.org/10.1073/pnas.1711978115</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_3KUymAj">N of 1 randomized trials for investigating new drugs</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heyting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jaeschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Adachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.1016/0197-2456(90)90003-k</idno>
		<ptr target="https://doi.org/10.1016/0197-2456(90)90003-k" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_jSpJYND">Controlled Clinical Trials</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="88" to="100" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guyatt, G. H., Heyting, A., Jaeschke, R., Keller, J., Adachi, J. D., &amp; Roberts, R. S. (1990). N of 1 randomized trials for investigating new drugs. Controlled Clinical Trials, 11(2), 88-100. https://doi.org/10.1016/0197- 2456(90)90003-k</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_9RyMMxF">The changing criterion design</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1901/jaba.1976.9-527</idno>
		<ptr target="https://doi.org/10.1901/jaba.1976.9-527" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_424YEgW">Journal of Applied Behavior Analysis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="527" to="532" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hartmann, D., &amp; Hall, R. V. (1976). The changing criterion design. Journal of Applied Behavior Analysis, 9(4), 527-532. https://doi.org/10.1901/jaba.1976.9-527</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_x76rPVV">Single case experimental design and empirical clinical practice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hayes</surname></persName>
		</author>
		<idno type="DOI">10.1037/0022-006x.49.2.193</idno>
		<ptr target="https://doi.org/10.1037/0022-006X.49.2.193" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_e7FvkmH">Journal of Consulting and Clinical Psychology</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="193" to="211" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hayes, S. C. (1981). Single case experimental design and empirical clinical practice. Journal of Consulting and Clinical Psychology, 49(2), 193-211. https://doi.org/10.1037/0022-006X.49.2.193</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_huzMyh7">Precision health: The role of the social and behavioral sciences in advancing the vision</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hekler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nebeker</surname></persName>
		</author>
		<idno type="DOI">10.1093/abm/kaaa018</idno>
		<ptr target="https://doi.org/10.1093/abm/kaaa018" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_q9FZH6x">Annals of Behavioral Medicine</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="805" to="826" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hekler, E., Tiro, J. A., Hunter, C. M., &amp; Nebeker, C. (2020). Precision health: The role of the social and behavioral sciences in advancing the vision. Annals of Behavioral Medicine, 54(11), 805-826. https://doi.org/10.1093/abm/kaaa018</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_vRJuMwn">Multiple-probe technique: A variation on the multiple baseline1</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Baer</surname></persName>
		</author>
		<idno type="DOI">10.1901/jaba.1978.11-189</idno>
		<ptr target="https://doi.org/10.1901/jaba.1978.11-189" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tG3jud5">Journal of Applied Behavior Analysis</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Horner, R. D., &amp; Baer, D. M. (1978). Multiple-probe technique: A variation on the multiple baseline1. Journal of Applied Behavior Analysis, 11(1), 189-196. https://doi.org/10.1901/jaba.1978.11-189</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_NSxvjVf">The use of single-subject research to identify evidence-based practice in special education</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Halle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcgee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Odom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolery</surname></persName>
		</author>
		<idno type="DOI">10.1177/001440290507100203</idno>
		<ptr target="https://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=2004-22378-004&amp;site=ehost-live" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MBm89rV">Exceptional Children</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="165" to="179" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Horner, R. H., Carr, E. G., Halle, J., McGee, G., Odom, S., &amp; Wolery, M. (2005). The use of single-subject research to identify evidence-based practice in special education. Exceptional Children, 71(2), 165-179. https://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=2004-22378-004&amp;site=ehost-live</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_t4RF4Zz">Single-case research designs: Methods for clinical and applied settings</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Kazdin</surname></persName>
		</author>
		<ptr target="https://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=2010-18971-000&amp;site=ehost-live" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_URydkne">Single-case research designs: Methods for clinical and applied settings</title>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>2nd ed.</note>
	<note type="raw_reference">Kazdin, A. E. (2011). Single-case research designs: Methods for clinical and applied settings. In Single-case research designs: Methods for clinical and applied settings (2nd ed.). Oxford University Press. https://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=2010-18971-000&amp;site=ehost-live</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_vVwv2hg">Single-case experimental designs: Characteristics, changes, and challenges</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Kazdin</surname></persName>
		</author>
		<idno type="DOI">10.1002/jeab.638</idno>
		<ptr target="https://doi.org/10.1002/jeab.638" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pj725JB">Journal of the Experimental Analysis of Behavior</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="85" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kazdin, A. E. (2021). Single-case experimental designs: Characteristics, changes, and challenges. Journal of the Experimental Analysis of Behavior, 115(1), 56-85. https://doi.org/10.1002/jeab.638</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_GSUgHNT">Caution regarding the use of pilot studies to guide power calculations for study proposals</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Kraemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mintz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Noda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tinklenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Yesavage</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.63.5.484</idno>
		<ptr target="https://doi.org/10.1001/archpsyc.63.5.484" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9jS3ekQ">Archives of General Psychiatry</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="484" to="489" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kraemer, H. C., Mintz, J., Noda, A., Tinklenberg, J., &amp; Yesavage, J. A. (2006). Caution regarding the use of pilot studies to guide power calculations for study proposals. In Archives of General Psychiatry, 63(5), 484- 489. https://doi.org/10.1001/archpsyc.63.5.484</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main" xml:id="_cAucHE5">Single-case research design and analysis: New directions for psychology and education</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kratochwill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hitchcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Odom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rindskopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Shadish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kratochwill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Levin</surname></persName>
		</author>
		<idno type="DOI">10.1177/0741932512452794</idno>
		<imprint>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kratochwill, T R, Hitchcock, J., Horner, R. H., Levin, J. R., Odom, S. L., Rindskopf, D. M., &amp; Shadish, W. R. Kratochwill, T. R. &amp; Levin, J. R. (1992). Single-case research design and analysis: New directions for psychology and education.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_UewVSXN">Enhancing the scientific credibility of single-case intervention research: Randomization to the rescue</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kratochwill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Levin</surname></persName>
		</author>
		<idno type="DOI">10.1037/a0017736</idno>
		<ptr target="https://doi.org/10.1037/a0017736" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_gEFXbSY">Psychological Methods</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="124" to="144" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kratochwill, T. R., &amp; Levin, J. R. (2010). Enhancing the scientific credibility of single-case intervention research: Randomization to the rescue. Psychological Methods, 15(2), 124-144. https://doi.org/10.1037/a0017736</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main" xml:id="_cJBjFHh">Single-case research design and analysis: New directions for psychology and education</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kratochwill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Levin</surname></persName>
		</author>
		<idno type="DOI">10.4324/9781315725994</idno>
		<ptr target="https://doi.org/10.4324/9781315725994" />
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>Routledge</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Kratochwill, T. R., &amp; Levin, J. R. (2015). Single-case research design and analysis: New directions for psychology and education. Routledge. https://doi.org/10.4324/9781315725994</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_9fduYAT">Single-case intervention research design standards</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kratochwill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Hitchcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Odom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rindskopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Shadish</surname></persName>
		</author>
		<idno type="DOI">10.1177/0741932512452794</idno>
		<ptr target="https://doi.org/10.1177/0741932512452794" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_YhmRvF3">Remedial and Special Education</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="26" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kratochwill, T. R, Hitchcock, J. H., Horner, R. H., Levin, J. R., Odom, S. L., Rindskopf, D. M., &amp; Shadish, W. R. (2013). Single-case intervention research design standards. Remedial and Special Education, 34(1), 26-38. https://doi.org/10.1177/0741932512452794</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_MzPZjzZ">Conduct and implementation of personalized trials in research and practice</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kravitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Duan</surname></persName>
		</author>
		<idno type="DOI">10.1162/99608f92.901255e7</idno>
		<ptr target="https://doi.org/10.1162/99608f92" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_f5mdBnY">Harvard Data Science Review</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Special Issue 3</note>
	<note type="raw_reference">Kravitz, R., &amp; Duan, N. (2022). Conduct and implementation of personalized trials in research and practice. Harvard Data Science Review, (Special Issue 3). https://doi.org/10.1162/99608f92.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title/>
		<idno type="DOI">10.1162/99608f92.901255e7</idno>
		<imprint>
			<biblScope unit="page" from="901255" to="e901257" />
		</imprint>
	</monogr>
	<note type="raw_reference">901255e7</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_Tde8mn2">Effect of mobile device-supported single-patient multi-crossover trials on treatment of chronic musculoskeletal pain: A randomized clinical trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kravitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wilsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Hays</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jerant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Servadio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Haddad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sim</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2018.3981</idno>
		<ptr target="https://doi.org/10.1001/jamainternmed.2018.3981" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ugqUPKx">JAMA Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1368" to="1377" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kravitz, R. L., Schmid, C. H., Marois, M., Wilsey, B., Ward, D., Hays, R. D., Duan, N., Wang, Y., MacDonald, S., Jerant, A., Servadio, J. L., Haddad, D., &amp; Sim, I. (2018). Effect of mobile device-supported single-patient multi-crossover trials on treatment of chronic musculoskeletal pain: A randomized clinical trial. JAMA Internal Medicine, 178(10), 1368-1377. https://doi.org/10.1001/jamainternmed.2018.3981</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_XqSnSHv">Evaluation of an intervention for apathy after traumatic brain injury: A multiple-baseline, single-case experimental design</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lane-Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tate</surname></persName>
		</author>
		<idno type="DOI">10.1097/htr.0b013e3181d98e1d</idno>
		<ptr target="https://doi.org/10.1097/HTR.0b013e3181d98e1d" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_awtNpQR">Journal of Head Trauma Rehabilitation</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="459" to="469" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lane-Brown, A., &amp; Tate, R. (2010). Evaluation of an intervention for apathy after traumatic brain injury: A multiple-baseline, single-case experimental design. Journal of Head Trauma Rehabilitation, 25(6), 459-469. https://doi.org/10.1097/HTR.0b013e3181d98e1d</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_VbkBTFR">The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Lillie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Patay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Diamant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Issell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Topol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Schork</surname></persName>
		</author>
		<idno type="DOI">10.2217/pme.11.7</idno>
		<ptr target="https://doi.org/10.2217/pme.11" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_G7yPsCy">Personalized Medicine</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="161" to="173" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., &amp; Schork, N. J. (2011). The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Personalized Medicine, 8(2), 161-173. https://doi.org/10.2217/pme.11.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_fnJWKuY">Single-case design, analysis, and quality assessment for intervention research</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moeyaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Cunha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Babik</surname></persName>
		</author>
		<idno type="DOI">10.1097/npt.0000000000000187</idno>
		<ptr target="https://doi.org/10.1097/NPT.0000000000000187" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XbKjDpW">Journal of Neurologic Physical Therapy</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="187" to="197" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lobo, M. A., Moeyaert, M., Cunha, A. B., &amp; Babik, I. (2017). Single-case design, analysis, and quality assessment for intervention research. Journal of Neurologic Physical Therapy, 41(3), 187-197. https://doi.org/10.1097/NPT.0000000000000187</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_bVfEeKB">The best kept secret in counseling: Single-case (N = 1) experimental designs</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lundervold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Belwood</surname></persName>
		</author>
		<idno type="DOI">10.1002/j.1556-6676.2000.tb02565.x</idno>
		<ptr target="https://doi.org/10.1002/j.1556-6676.2000.tb02565.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_mzxEGAB">Journal of Counseling and Development</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="102" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lundervold, D. A., &amp; Belwood, M. F. (2000). The best kept secret in counseling: Single-case (N = 1) experimental designs. Journal of Counseling and Development, 78(1), 92-102. https://doi.org/10.1002/j.1556- 6676.2000.tb02565.x</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_3p29Yx9">Quantitative techniques and graphical representations for interpreting results from alternating treatment design</title>
		<author>
			<persName><forename type="first">R</forename><surname>Manolov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tanious</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Onghena</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40614-021-00289-9</idno>
		<ptr target="https://doi.org/10.1007/s40614-021-00289-9HarvardData" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NQwsR89">Perspectives on Behavior Science</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>Advance online Science Review Special Issue 3: Personalized (N-of-1 The Family of Single-Case Experimental Designs 19</note>
	<note type="raw_reference">Manolov, R., Tanious, R., &amp; Onghena, P. (2021). Quantitative techniques and graphical representations for interpreting results from alternating treatment design. Perspectives on Behavior Science. Advance online publication. https://doi.org/10.1007/s40614-021-00289-9 Harvard Data Science Review • Special Issue 3: Personalized (N-of-1) Trials The Family of Single-Case Experimental Designs 19</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_Ak5Expt">The state of the art and future opportunities for using longitudinal n-of-1 methods in health behaviour research: A systematic literature overview</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vieira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Sniehotta</surname></persName>
		</author>
		<idno type="DOI">10.1080/17437199.2017.1316672</idno>
		<ptr target="https://doi.org/10.1080/17437199.2017.1316672" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DzRWZMX">Health Psychology Review</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="307" to="323" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDonald, S., Quinn, F., Vieira, R., O&apos;Brien, N., White, M., Johnston, D. W., &amp; Sniehotta, F. F. (2017). The state of the art and future opportunities for using longitudinal n-of-1 methods in health behaviour research: A systematic literature overview. Health Psychology Review, 11(4), 307-323. https://doi.org/10.1080/17437199.2017.1316672</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_6KwBUfT">Internet-based group contingency management to promote abstinence from cigarette smoking: A feasibility study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Meredith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Grabinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dallery</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2011.02.012</idno>
		<ptr target="https://doi.org/10.1016/j.drugalcdep.2011.02.012" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DGrqQXm">Drug and Alcohol Dependence</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="23" to="30" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Meredith, S. E., Grabinski, M. J., &amp; Dallery, J. (2011). Internet-based group contingency management to promote abstinence from cigarette smoking: A feasibility study. Drug and Alcohol Dependence, 118(1), 23-30. https://doi.org/10.1016/j.drugalcdep.2011.02.012</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_ru5Cahu">Using Bayesian methods to test mediators of intervention outcomes in single-case experimental designs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Miočević</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Klaassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Geuke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moeyaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maric</surname></persName>
		</author>
		<idno type="DOI">10.1080/17489539.2020.1732029</idno>
		<ptr target="https://doi.org/10.1080/17489539.2020.1732029" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xyNgjaP">Evidence-Based Communication Assessment and Intervention</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="52" to="68" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miočević, M., Klaassen, F., Geuke, G., Moeyaert, M., &amp; Maric, M. (2020). Using Bayesian methods to test mediators of intervention outcomes in single-case experimental designs. Evidence-Based Communication Assessment and Intervention, 14(1-2), 52-68. https://doi.org/10.1080/17489539.2020.1732029</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_tDzxuCp">Quantitative synthesis of personalized trials studies: Meta-analysis of aggregated data versus individual patient data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moeyaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fingerhut</surname></persName>
		</author>
		<idno type="DOI">10.1162/99608f92.3574f1dc</idno>
		<ptr target="https://doi.org/10.1162/99608f92" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MaZbgZw">Harvard Data Science Review</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Special Issue 3</note>
	<note type="raw_reference">Moeyaert, M., &amp; Fingerhut, J. (2022). Quantitative synthesis of personalized trials studies: Meta-analysis of aggregated data versus individual patient data. Harvard Data Science Review, (Special Issue 3). https://doi.org/10.1162/99608f92.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title/>
		<idno type="DOI">10.1162/99608f92.3574f1dc</idno>
		<imprint>
			<biblScope unit="page" from="3574" to="3575" />
		</imprint>
	</monogr>
	<note type="raw_reference">3574f1dc</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_MEBaarx">Single-participant research design: Bringing science to managed care</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Morgan</surname></persName>
		</author>
		<idno type="DOI">10.1037/0003-066x.56.2.119</idno>
		<ptr target="https://doi.org/10.1037/0003-066X.56.2.119" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_uVd2Hca">American Psychologist</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="119" to="127" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morgan, D. L., &amp; Morgan, R. K. (2001). Single-participant research design: Bringing science to managed care. American Psychologist, 56(2), 119-127. https://doi.org/10.1037/0003-066X.56.2.119</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<idno type="DOI">10.1089/acm.2021.0197</idno>
		<ptr target="https://www.nccih.nih.gov/grants/pilot-studies-common-uses-and-misuses" />
		<title level="m" xml:id="_Py22s5T">Pilot studies: Common uses and misuses</title>
		<imprint>
			<publisher>National Institutes of Health</publisher>
			<date type="published" when="2020-05-18">2020, May 18</date>
		</imprint>
	</monogr>
	<note type="raw_reference">National Center for Complementary and Integrative Health. (2020, May 18). Pilot studies: Common uses and misuses. National Institutes of Health. https://www.nccih.nih.gov/grants/pilot-studies-common-uses-and- misuses</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_JPDjVwD">Less is more: Psychologists can learn more by studying fewer people</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Normand</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpsyg.2016.00934</idno>
		<ptr target="https://doi.org/10.3389/fpsyg.2016.00934" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_3fDSnWE">Frontiers in Psychology</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">94</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Normand, M. P. (2016). Less is more: Psychologists can learn more by studying fewer people. In Frontiers in Psychology, 7(94). https://doi.org/10.3389/fpsyg.2016.00934</note>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main" xml:id="_WUPBx5d">Conditioned reflexes</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">P</forename><surname>Pavlov</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1927">1927</date>
			<publisher>Clarendon Press</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Pavlov, I. P. (1927). Conditioned reflexes. Clarendon Press.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_genw4Nj">N-of-1 trials, their reporting guidelines, and the advancement of open science principles</title>
		<author>
			<persName><forename type="first">A</forename><surname>Porcino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vohra</surname></persName>
		</author>
		<idno type="DOI">10.1162/99608f92.a65a257a</idno>
		<ptr target="https://doi.org/10.1162/99608f92" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_vwtDf2m">Harvard Data Science Review</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Special Issue 3</note>
	<note type="raw_reference">Porcino, A., &amp; Vohra, S. (2022). N-of-1 trials, their reporting guidelines, and the advancement of open science principles. Harvard Data Science Review, (Special Issue 3). https://doi.org/10.1162/99608f92.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title/>
		<idno type="DOI">10.1162/99608f92.a65a257a</idno>
		<imprint>
			<biblScope unit="page" from="65" to="257" />
		</imprint>
	</monogr>
	<note type="raw_reference">a65a257a</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_APpfBdz">Procedural sensitivities of effect sizes for single-case designs with directly observed behavioral outcome measures</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Pustejovsky</surname></persName>
		</author>
		<idno type="DOI">10.1037/met0000179</idno>
		<ptr target="https://doi.org/10.1037/met0000179" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_uKANvAK">Psychological Methods</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="217" to="235" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pustejovsky, J. E. (2019). Procedural sensitivities of effect sizes for single-case designs with directly observed behavioral outcome measures. Psychological Methods, 24(2), 217-235. https://doi.org/10.1037/met0000179</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_XHyyP2V">Identifying mechanisms of change: Utilizing single-participant methodology to better understand behavior therapy for child depression</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Gaynor</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145445514530756</idno>
		<ptr target="https://doi.org/10.1177/0145445514530756" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PAYSGhg">Behavior Modification</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="636" to="664" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riley, A. R., &amp; Gaynor, S. T. (2014). Identifying mechanisms of change: Utilizing single-participant methodology to better understand behavior therapy for child depression. Behavior Modification, 38(5), 636- 664. https://doi.org/10.1177/0145445514530756</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_YJuCMQj">Rapid, responsive, relevant (R3) research: A call for a rapid learning health research enterprise</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Glasgow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Etheredge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Abernethy</surname></persName>
		</author>
		<idno type="DOI">10.1186/2001-1326-2-10</idno>
		<ptr target="https://doi.org/10.1186/2001-1326-2-10" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xnkt2yX">Clinical and Translational Medicine</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riley, W. T., Glasgow, R. E., Etheredge, L., &amp; Abernethy, A. P. (2013). Rapid, responsive, relevant (R3) research: A call for a rapid learning health research enterprise. Clinical and Translational Medicine, 2(1), Article e10. https://doi.org/10.1186/2001-1326-2-10</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_vUsQRWy">On-demand sildenafil as a treatment for raynaud phenomenon: A series of n-of-1 trials</title>
		<author>
			<persName><forename type="first">M</forename><surname>Roustit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Giai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gaget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Khouri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mouhib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lotito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blaise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Seinturier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Subtil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cracowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Imbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carpentier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vohra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cracowski</surname></persName>
		</author>
		<idno type="DOI">10.7326/m18-0517</idno>
		<ptr target="https://doi.org/10.7326/M18-0517" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_3dzEu3t">Annals of Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="694" to="703" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roustit, M., Giai, J., Gaget, O., Khouri, C., Mouhib, M., Lotito, A., Blaise, S., Seinturier, C., Subtil, F., Paris, A., Cracowski, C., Imbert, B., Carpentier, P., Vohra, S., &amp; Cracowski, J. L. (2018). On-demand sildenafil as a treatment for raynaud phenomenon: A series of n-of-1 trials. Annals of Internal Medicine, 169(10), 694-703. https://doi.org/10.7326/M18-0517</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_M6JWUEb">A further refinement of procedures addressing food selectivity</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Croner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chirinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Weiss</surname></persName>
		</author>
		<idno type="DOI">10.1002/bin.1686</idno>
		<ptr target="https://doi.org/10.1002/bin.1686" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zV4deAd">Behavioral Interventions</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="495" to="503" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Russo, S. R., Croner, J., Smith, S., Chirinos, M., &amp; Weiss, M. J. (2019). A further refinement of procedures addressing food selectivity. Behavioral Interventions, 34(4), 495-503. https://doi.org/10.1002/bin.1686</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_DEKyvEH">Personalized medicine: Time for one-person trials</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Schork</surname></persName>
		</author>
		<idno type="DOI">10.1038/520609a</idno>
		<ptr target="https://doi.org/10.1038/520609a" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZVR4v8r">Nature</title>
		<imprint>
			<biblScope unit="volume">520</biblScope>
			<biblScope unit="issue">7549</biblScope>
			<biblScope unit="page" from="609" to="611" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schork N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609-611. https://doi.org/10.1038/520609a</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_HzenZfr">Accommodating serial correlation and sequential design elements in personalized studies and aggregated personalized studies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Schork</surname></persName>
		</author>
		<idno type="DOI">10.1162/99608f92.f1eef6f4</idno>
		<ptr target="https://doi.org/10.1162/99608f92" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_qqYbqaR">Harvard Data Science Review</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Special Issue 3</note>
	<note type="raw_reference">Schork, N. (2022). Accommodating serial correlation and sequential design elements in personalized studies and aggregated personalized studies. Harvard Data Science Review, (Special Issue 3). https://doi.org/10.1162/99608f92.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<monogr>
		<title/>
		<idno type="DOI">10.1162/99608f92.f1eef6f4</idno>
		<imprint/>
	</monogr>
	<note type="raw_reference">f1eef6f4</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_ZFZuTZG">Single-subject studies in translational nutrition research</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Schork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Goetz</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev-nutr-071816-064717</idno>
		<ptr target="https://doi.org/10.1146/annurev-nutr-071816-064717" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5zUZECy">Annual Review of Nutrition</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="395" to="422" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schork, N. J., &amp; Goetz, L. H. (2017). Single-subject studies in translational nutrition research. Annual Review of Nutrition, 37, 395-422. https://doi.org/10.1146/annurev-nutr-071816-064717</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_4FCP2my">Lost in translation: The valley of death across preclinical and clinical divide -Identification of problems and overcoming obstacles</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Seyhan</surname></persName>
		</author>
		<idno type="DOI">10.1186/s41231-019-0050-7</idno>
		<ptr target="https://doi.org/10.1186/s41231-019-0050-7" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BHfYE6m">Translational Medicine Communications</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seyhan, A. A. (2019). Lost in translation: The valley of death across preclinical and clinical divide - Identification of problems and overcoming obstacles. Translational Medicine Communications, 4(1), Article 18. https://doi.org/10.1186/s41231-019-0050-7</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_ueSsKKA">Analysis and meta-analysis of single-case designs: An introduction</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Shadish</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsp.2013.11.009</idno>
		<ptr target="https://doi.org/10.1016/j.jsp.2013.11.009" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_P2wkKs2">Journal of School Psychology</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="109" to="122" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shadish, W. R. (2014). Analysis and meta-analysis of single-case designs: An introduction. Journal of School Psychology, 52(2), 109-122. https://doi.org/10.1016/j.jsp.2013.11.009</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_NjZ4aaV">Analysis and meta-analysis of single-case designs with a standardized mean difference statistic: A primer and applications</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Shadish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Hedges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Pustejovsky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsp.2013.11.005</idno>
		<ptr target="https://doi.org/10.1016/j.jsp.2013.11.005" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2hV4E3Q">Journal of School Psychology</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="123" to="147" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shadish, W. R., Hedges, L. V., &amp; Pustejovsky, J. E. (2014). Analysis and meta-analysis of single-case designs with a standardized mean difference statistic: A primer and applications. Journal of School Psychology, 52(2), 123-147. https://doi.org/10.1016/j.jsp.2013.11.005</note>
</biblStruct>

<biblStruct xml:id="b62">
	<monogr>
		<title level="m" type="main" xml:id="_kRcQdcF">Tactics of scientific research</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sidman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1960">1960</date>
			<publisher>Basic Books</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sidman, M. (1960). Tactics of scientific research. Basic Books.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_CEQ7zcY">Smoking cessation through cigarette-fading, self-recording, and contracting: Treatment, maintenance and long-term followup</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Leung</surname></persName>
		</author>
		<idno type="DOI">10.1016/0306-4603(88)90033-0</idno>
		<ptr target="https://doi.org/10.1016/0306-4603(88)90033-0" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NnJxKFB">Addictive Behaviors</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="101" to="105" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singh, N. N., &amp; Leung, J. P. (1988). Smoking cessation through cigarette-fading, self-recording, and contracting: Treatment, maintenance and long-term followup. Addictive Behaviors, 13(1), 101-105. https://doi.org/10.1016/0306-4603(88)90033-0</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_PRDnW6u">Single-case experimental designs for behavioral neuroscience</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Soto</surname></persName>
		</author>
		<idno type="DOI">10.1002/jeab.633</idno>
		<ptr target="https://doi.org/10.1002/jeab.633" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BA3VnM8">Journal of the Experimental Analysis of Behavior</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="447" to="467" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Soto, P. L. (2020). Single-case experimental designs for behavioral neuroscience. Journal of the Experimental Analysis of Behavior, 114(3), 447-467. https://doi.org/10.1002/jeab.633</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_CYHnU6e">Hierarchical linear models for the quantitative integration of effect sizes in single-case research</title>
		<author>
			<persName><forename type="first">W</forename><surname>Van Den Noortgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Onghena</surname></persName>
		</author>
		<idno type="DOI">10.3758/bf03195492</idno>
		<ptr target="https://doi.org/10.3758/bf03195492" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_by9rxhR">Behavior Research Methods, Instruments, &amp; Computers</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Van den Noortgate, W., &amp; Onghena, P. (2003). Hierarchical linear models for the quantitative integration of effect sizes in single-case research. Behavior Research Methods, Instruments, &amp; Computers, 35(1), 1-10. https://doi.org/10.3758/bf03195492</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_W5S5mwU">Results reporting in single case experiments and single case meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Vannest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Peltier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haas</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ridd.2018.04.029</idno>
		<ptr target="https://doi.org/10.1016/j.ridd.2018.04.029" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2FBSjCy">Research in Developmental Disabilities</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="10" to="18" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vannest, K. J., Peltier, C., &amp; Haas, A. (2018). Results reporting in single case experiments and single case meta-analysis. Research in Developmental Disabilities, 79, 10-18. https://doi.org/10.1016/j.ridd.2018.04.029</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_urPZ4ff">From boulder to stockholm in 70 years: Single case experimental designs in clinical research</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W S</forename><surname>Vlaeyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Wicksell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gentili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Tate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vohra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Punja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Linton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Sniehotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Onghena</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40732-020-00402-5</idno>
		<ptr target="https://doi.org/10.1007/s40732-020-00402-5" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Eyt5SEh">Psychological Record</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="659" to="670" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vlaeyen, J. W. S., Wicksell, R. K., Simons, L. E., Gentili, C., De, T. K., Tate, R. L., Vohra, S., Punja, S., Linton, S. J., Sniehotta, F. F., &amp; Onghena, P. (2020). From boulder to stockholm in 70 years: Single case experimental designs in clinical research. Psychological Record, 70(4), 659-670. https://doi.org/10.1007/s40732-020-00402-5</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_8Tn6stk">A case for n-of-1 trials</title>
		<author>
			<persName><forename type="first">S</forename><surname>Vohra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Punja</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2018.7166</idno>
		<ptr target="https://doi.org/10.1001/jamainternmed.2018.7166" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_dQgwHgD">JAMA Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">452</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vohra, S., Punja, S. (2019). A case for n-of-1 trials. JAMA Internal Medicine, 179(3), 452. https://doi.org/10.1001/jamainternmed.2018.7166</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_PJfTuKQ">CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement</title>
		<author>
			<persName><forename type="first">S</forename><surname>Vohra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shamseer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bukutu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nikles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Zucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kravitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2015.05.004</idno>
		<ptr target="https://doi.org/10.1016/j.jclinepi.2015.05.004" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DSKUduy">Journal of Clinical Epidemiology</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="9" to="17" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vohra, S., Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Tate, R., Nikles, J., Zucker, D. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., &amp; CENT Group (2016). CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. Journal of Clinical Epidemiology, 76, 9-17. https://doi.org/10.1016/j.jclinepi.2015.05.004</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_mqHetXZ">Component analyses using single-subject experimental designs: A review</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ward-Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sturmey</surname></persName>
		</author>
		<idno type="DOI">10.1901/jaba.2010.43-685</idno>
		<ptr target="https://doi.org/10.1901/jaba.2010.43-685" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5dkQdUa">Journal of Applied Behavior Analysis</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="685" to="704" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ward-Horner, J., &amp; Sturmey, P. (2010). Component analyses using single-subject experimental designs: A review. Journal of Applied Behavior Analysis, 43(4), 685-704. https://doi.org/10.1901/jaba.2010.43-685</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_rxbqV9F">The evaluation of heart rate biofeedback using a multi-element design</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Weems</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-7916(98)00005-6</idno>
		<ptr target="https://doi.org/10.1016/S0005-7916(98)00005-6" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QaV29z7">Journal of Behavior Therapy and Experimental Psychiatry</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="157" to="162" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weems, C. F. (1998). The evaluation of heart rate biofeedback using a multi-element design. Journal of Behavior Therapy and Experimental Psychiatry, 29(2), 157-162. https://doi.org/10.1016/S0005- 7916(98)00005-6</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_DkbHcjE">A multicomponent behavioral intervention for smoking cessation during pregnancy: A nonconcurrent multiple-baseline design</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Justicia-Linde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Thor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haghdel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<idno type="DOI">10.1093/tbm/iby027</idno>
		<ptr target="https://doi.org/10.1093/tbm/iby027" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DstfyUF">Translational Behavioral Medicine</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="308" to="318" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wen, X., Eiden, R. D., Justicia-Linde, F. E., Wang, Y., Higgins, S. T., Thor, N., Haghdel, A., Peters, A. R., &amp; Epstein, L. H. (2019). A multicomponent behavioral intervention for smoking cessation during pregnancy: A nonconcurrent multiple-baseline design. Translational Behavioral Medicine, 9(2), 308-318. https://doi.org/10.1093/tbm/iby027</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_VF9naTJ">Perils of evidence-based medicine</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1353/pbm.0.0132</idno>
		<ptr target="https://doi.org/10.1353/pbm.0.0132" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9MHupN7">Perspectives in Biology and Medicine</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="106" to="120" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Williams, B. A. (2010). Perils of evidence-based medicine. Perspectives in Biology and Medicine, 53(1), 106- 120. https://doi.org/10.1353/pbm.0.0132</note>
</biblStruct>

<biblStruct xml:id="b74">
	<monogr>
		<author>
			<persName><forename type="first">Leonard</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jesse</forename><surname>Dallery</surname></persName>
		</author>
		<title level="m" xml:id="_NXVJAET">This article is licensed under a Creative Commons Attribution</title>
		<imprint/>
	</monogr>
	<note>CC BY 4.0) International license, except where otherwise indicated with respect to particular material included in the article</note>
	<note type="raw_reference">©2022 Leonard H. Epstein and Jesse Dallery. This article is licensed under a Creative Commons Attribution (CC BY 4.0) International license, except where otherwise indicated with respect to particular material included in the article.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
